| [1] |
Ostermann M. Diagnosis of acute kidney injury: Kidney Disease Improving Global Outcomes criteria and beyond[J]. Curr Opin Crit Care, 2014, 20(6): 581–587.
|
| [2] |
Palevsky PM, Liu KD, Brophy PD, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury[J]. Am J Kidney Dis, 2013, 61(5): 649–672.
|
| [3] |
Kellum JA, Sileanu FE, Murugan R, et al. Classifying AKI by urine output versus serum creatinine level[J]. J Am Soc Nephrol, 2015, 26(9): 2231–2238.
|
| [4] |
Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study[J]. Intensive Care Med, 2015, 41(8): 1411–1423.
|
| [5] |
Thomas ME, Blaine C, Dawnay A, et al. The definition of acute kidney injury and its use in practice[J]. Kidney Int, 2015, 87(1): 62–73.
|
| [6] |
Lehner GF, Forni LG, Joannidis M. Oliguria and biomarkers of acute kidney injury: star struck lovers or strangers in the night[J]. Nephron, 2016, 134(3): 183–190.
|
| [7] |
Schrezenmeier EV, Barasch J, Budde K, et al. Biomarkers in acute kidney injury- pathophysiological basis and clinical performance[J]. Acta Physiol (Oxf), 2017, 219(3): 554–572.
|
| [8] |
Katagiri D, Doi K, Honda K, et al. Combination of two urinary biomarkers predicts acute kidney injury after adult cardiac surgery[J]. Ann Thorac Surg, 2012, 93(2): 577–583.
|
| [9] |
Maisel AS, Katz N, Hillege HL, et al. Biomarkers in kidney and heart disease[J]. Nephrol Dial Transplant, 2011, 26(1): 62–74.
|
| [10] |
Khwaja A. KDIGO clinical practice guidelines for acute kidney injury[J]. Nephron Clin Pract, 2012, 120(4): c179–c184.
|
| [11] |
Malhotra R, Siew ED. Biomarkers for the early detection and prognosis of acute kidney injury[J]. Clin J Am Soc Nephrol, 2017, 12(1): 149–173.
|
| [12] |
Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure- definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group[J]. Crit Care, 2004, 8(4): R204–R12.
|
| [13] |
Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury[J]. Crit Care, 2007, 11(2): R31.
|
| [14] |
Schiffl H, Lang SM. Update on biomarkers of acute kidney injury: moving closer to clinical impact[J]. Mol Diagn Ther, 2012, 16(4): 199–207.
|
| [15] |
Bastin A J, Ostermann M, Slack A J, et al. Acute kidney injury after cardiac surgery according to Risk/Injury/Failure/Loss/End-stage, Acute Kidney Injury Network, and Kidney Disease: Improving Global Outcomes classifications[J]. Journal of Critical Care, 2013, 28(4): 389–396.
|
| [16] |
Chawla LS, Davison DL, Brasha-Mitchell E, et al. Development and standardization of a furosemide stress test to predict the severity of acute kidney injury[J]. Crit Care, 2013, 17(5): R207.
|
| [17] |
Joannidis M, Metnitz B, Bauer P, et al. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database[J]. Intensive Care Med, 2009, 35(10): 1692–1702.
|
| [18] |
Dennen P, Douglas IS, Anderson R. Acute kidney injury in the intensive care unit: an update and primer for the intensivist[J]. Crit Care Med, 2010, 38(1): 261–275.
|
| [19] |
Kellum JA, Devarajan P. What can we expect from biomarkers for acute kidney injury[J]. Biomark Med, 2014, 8(10): 1239–1245.
|
| [20] |
Koyner JL, Davison DL, Brasha-Mitchell E, et al. Furosemide stress test and biomarkers for the prediction of AKI severity[J]. J Am Soc Nephrol, 2015, 26(8): 2023–2031.
|
| [21] |
Liu KD, Thompson BT, Ancukiewicz M, et al. Acute kidney injury in patients with acute lung injury: impact of fluid accumulation on classification of acute kidney injury and associated outcomes[J]. Crit Care Med, 2011, 39(12): 2665–2671.
|
| [22] |
Ling W, Zhaohui N, Ben H, et al. Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography[J]. Nephron Clinical Practice, 2008, 108(3): c176–c181.
|
| [23] |
Filiopoulos V, Biblaki D, Vlassopoulos D. Neutrophil gelatinase-associated lipocalin (NGAL): a promising biomarker of contrast-induced nephropathy after computed tomography[J]. Ren Fail, 2014, 36(6): 979–986.
|
| [24] |
Luo QH, Chen ML, Chen ZL, et al. Evaluation of KIM-1 and NGAL as early indicators for assessment of gentamycin-induced nephrotoxicity in vivo and in vitro[J]. Kidney Blood Press Res, 2016, 41(6): 911–918.
|
| [25] |
Bennett M, Dent CL, Ma Q, et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study[J]. Clin J Am Soc Nephrol, 2008, 3(3): 665–673.
|
| [26] |
Hewitt SM, Dear J, Star RA. Discovery of protein biomarkers for renal diseases[J]. J Am Soc Nephrol, 2004, 15(7): 1677–1689.
|
| [27] |
Siew ED, Matheny ME. Choice of reference serum creatinine in defining acute kidney injury[J]. Nephron, 2015, 131(2): 107–112.
|
| [28] |
Vanmassenhove J, Glorieux G, Hoste E, et al. Urinary output and fractional excretion of sodium and urea as indicators of transient versus intrinsic acute kidney injury during early sepsis[J]. Critical Care, 2013, 17(5): R234.
|
| [29] |
Huang Y, Don-Wauchope AC. The clinical utility of kidney injury molecule 1 in the prediction, diagnosis and prognosis of acute kidney injury: a systematic review[J]. Inflamm Allergy Drug Targets, 2011, 10(4): 260–271.
|
| [30] |
Ramesh G, Krawczeski CD, Woo JG, et al. Urinary netrin-1 is an early predictive biomarker of acute kidney injury after cardiac surgery[J]. Clin J Am Soc Nephrol, 2010, 5(3): 395–401.
|
| [31] |
Munshi R, Johnson A, Siew ED, et al. MCP-1 gene activation marks acute kidney injury[J]. J Am Soc Nephrol, 2011, 22(1): 165–175.
|
| [32] |
Doi K, Noiri E, Sugaya T. Urinary L-type fatty acid-binding protein as a new renal biomarker in critical care[J]. Curr Opin Crit Care, 2010, 16(6): 545–549.
|
| [33] |
Krawczeski CD, Goldstein SL, Woo JG, et al. Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass[J]. J Am Coll Cardiol, 2011, 58(22): 2301–2309.
|
| [34] |
Stetler-Stevenson WG. Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities[J]. Sci Signal, 2008, 1(27): re6.
|
| [35] |
Erdener D, Aksu K, Biçer I, et al. Urinary N-acetyl-beta-D-glucosaminidase (NAG) in lupus nephritis and rheumatoid arthritis[J]. J Clin Lab Anal, 2005, 19(4): 172–176.
|
| [36] |
Brown JR, Hisey WM, Marshall EJ, et al. Acute kidney injury severity and long-term readmission and mortality after cardiac surgery[J]. Ann Thorac Surg, 2016, 102(5): 1482–1489.
|
| [37] |
Gilquin B, Louwagie M, Jaquinod M, et al. Multiplex and accurate quantification of acute kidney injury biomarker candidates in urine using Protein Standard Absolute Quantification (PSAQ) and targeted proteomics[J]. Talanta, 2017, 164: 77–84.
|
| [38] |
Kadioglu T, Uzunlulu M, Yigit Kaya S, et al. Urinary kidney injury molecule-1 levels as a marker of early kidney injury in hypertensive patients[J]. Italian J Urol Nephrol, 2016, 68(5): 456–461.
|
| [39] |
Schetz M, Gunst J, Van den Berghe G. The impact of using estimated GFR versus creatinine clearance on the evaluation of recovery from acute kidney injury in the ICU[J]. Intensive Care Med, 2014, 40(11): 1709–1717.
|
| [40] |
Zhou D, Tan R J, Lin L, et al. Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury[J]. Kidney Int, 2013, 84(3): 509–520.
|
| [41] |
Ichimura T, Asseldonk EJ, Humphreys BD, et al. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells[J]. J Clin Invest, 2008, 118(5): 1657–1668.
|
| [42] |
Groesbeck D, Kottgen A, Parekh R, et al. Age, gender, and race effects on cystatin C levels in US adolescents[J]. Clin J Am Soc Nephrol, 2008, 3(6): 1777–1785.
|
| [43] |
Parikh C R, Mishra J, Thiessen-Philbrook H, et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery[J]. Kidney Int, 2006, 70(1): 199–203.
|